Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 3/20 | 0.34 |
| ▸ | RAF1 | P04049 | 6/20 | 0.34 |
| ▸ | PIK3CD | O00329 | 4/20 | 0.34 |
| ▸ | PDE2A | O00408 | 1/20 | 0.32 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.32 |
| ▸ | BRAF | P15056 | 3/20 | 0.31 |
| ▸ | ACACB | O00763 | 1/20 | 0.31 |
| ▸ | HCRTR1 | O43613 | 2/20 | 0.31 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31268966 | 0.96 | DRD2 (0.34) | DRD2RAF1PIK3CDPDE2APDE10A | |
| SCHEMBL31269155 | 0.91 | TLR7 (0.34) | DRD2PIK3CD | |
| SCHEMBL31269351 | 0.91 | PIK3CD (0.35) | PIK3CDPDE2APDE10A | |
| SCHEMBL30983456 | 0.91 | PIK3CD (0.35) | PIK3CDPDE2APDE10A | |
| SCHEMBL31269042 | 0.90 | DRD2 (0.38) | DRD2PIK3CDACACB | |
| SCHEMBL31268977 | 0.89 | DRD2 (0.34) | DRD2PIK3CD | |
| SCHEMBL30983576 | 0.88 | DRD2 (0.41) | DRD2PIK3CDPDE2A | |
| SCHEMBL31268935 | 0.87 | PDE2A (0.34) | PIK3CDPDE2APDE10A | |
| SCHEMBL31269005 | 0.87 | PDE2A (0.35) | PIK3CDPDE2APDE10A | |
| SCHEMBL31268917 | 0.87 | PIK3CD (0.32) | PIK3CDPDE2APDE10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4689155-A1 | USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS | Astrazeneca AB (SE) | 2026-02-11 | — | — | EP | disclosed |
| WO-2024201368-A1 | USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS | ASTRAZENECA AB (SE) | 2024-10-03 | — | — | WO | disclosed |